# Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

> **NCT00031551** · PHASE2 · TERMINATED · sponsor: **National Institute of Nursing Research (NINR)** · enrollment: 27 (actual)

## Conditions studied

- Stomatitis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00031551
- **Lead sponsor:** National Institute of Nursing Research (NINR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** It was not feasible to recruit required sample size from two clinical sites.
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031551, "Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00031551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*